GlobeNewswire Inc.·Mar 24·NaProgressive Raises $1.5B in Senior Notes as Insurer Taps Bond MarketProgressive raises $1.5B through senior notes offering at 4.60% and 5.15% coupons, with Goldman Sachs and TD Securities as joint bookrunners. PGRcapital raisingfixed income
Benzinga·Mar 24·Globe NewswireEV Maker LOBO Prices $2M Public Offering to Fund DevelopmentLOBO Technologies prices $2M public offering of 3.9M units at $0.51 each, with proceeds for EV development and working capital. LOBOwarrantspublic offering
GlobeNewswire Inc.·Mar 24·NaSol-Gel Raises $33.1M via Oversubscribed Offering to Advance Rare Disease PipelineSol-Gel Technologies prices 459,112 shares at $72 each, raising $33.1M for SGT-610 development in Gorlin syndrome treatment. SLGLPhase 3 clinical trialequity offering
The Motley Fool·Mar 24·Ryan VanzoNHTSA Escalates Tesla FSD Probe as Robotaxi Bet Faces Critical ScrutinyNHTSA intensifies Full Self-Driving investigation across 3.2M Tesla vehicles over visibility concerns. Potential recall threatens robotaxi ambitions underpinning $1.2T valuation. TSLAautonomous vehiclesvaluation concerns
The Motley Fool·Mar 24·Leo SunChewy Stock at Crossroads: Can Stabilizing Business Justify Valuation Ahead of Q4 Earnings?Chewy reports Q4 earnings March 25 after 70% five-year decline. Growing subscriptions and marketplace ads suggest undervaluation at 9x EBITDA. AMZNCHWYvaluationearnings report
The Motley Fool·Mar 24·James BrumleyPeloton's Crumbling Moat: Why Structural Headwinds Make $PTON a Cautionary TalePeloton faces two insurmountable challenges: zero competitive moat against cheaper rivals and cyclical fitness industry with low stickiness. Membership fell 17% to 5.8M; revenue collapsed to $2.5B. AAPLPTONcompetitive moatPeloton Interactive
GlobeNewswire Inc.·Mar 23·Rosen Law FirmPLUG Power Faces Securities Lawsuit Over Misleading DOE Loan ClaimsPlug Power investors face April 3, 2026 deadline to join securities lawsuit alleging misleading DOE loan fund statements and hydrogen facility construction misrepresentations. PLUGsecurities class actionlead plaintiff deadline
GlobeNewswire Inc.·Mar 23·The Rosen Law FirmHub Group Restates 2025 Financials After Accounting Error; Stock Plunges 18.3%$HUBG tumbled 18.3% after revealing accounting errors in Q1-Q3 2025 results, understating transportation costs and payables. HUBGsecurities fraudclass action lawsuit
GlobeNewswire Inc.·Mar 23·Rosen Law FirmELWT Plunges on Accounting Restatement; Class Action Investigation LaunchedElauwit Connection ($ELWT) stock fell 6.8% after disclosing revenue recognition errors in its Q3 2025 filing. Securities litigation firm investigating potential class action claims. ELWTsecurities fraudclass action lawsuit
GlobeNewswire Inc.·Mar 23·Rosen Law FirmRosen Law Firm Files Class Action Against ODDITY Tech Over Alleged Ad Algorithm MisstatementsRosen Law Firm launches securities class action against ODDITY Tech ($ODD) for allegedly misleading investors about algorithm changes affecting customer acquisition costs. ODDsecurities fraudclass action lawsuit
Benzinga·Mar 23·Chris KatjeTrump's Iran Strikes Trigger Approval Slump as Markets Tumble on Geopolitical RiskTrump's approval rating falls to 42% after Iran military strikes. Voters oppose action; S&P 500 drops below $650 amid Middle East tensions and oil price surge. SPYoil pricesstock market decline
GlobeNewswire Inc.·Mar 23·NaGAP Refinances $1.12B Maturing Bonds Through Scotiabank Credit FacilityGrupo Aeroportuario del Pacífico refinances maturing bond certificates worth Ps.1,120 million through new 12-month Scotiabank facility at TIIE Funding plus 44 basis points. PACcredit facilitydebt refinancing
GlobeNewswire Inc.·Mar 23·Not SpecifiediDox.ai Launches Guardrail Platform to Combat AI Agent Security VulnerabilitiesiDox.ai launches Guardrail AI governance platform with real-time monitoring to prevent autonomous agent security vulnerabilities like those exposed by OpenClaw research. NVDAAI agentscompliance
GlobeNewswire Inc.·Mar 23·Rosen Law FirmREGENXBIO Faces Securities Lawsuit Over Gene Therapy Trial DisclosuresRosen Law Firm recruits investors for securities class action against REGENXBIO over alleged RGX-111 gene therapy misstatements. Lead plaintiff deadline: April 14, 2026. RGNXsecurities class actionmaterial misstatement
GlobeNewswire Inc.·Mar 23·FiverrFiverr's AI Video Hub Disrupts Hollywood Model With Budget-Friendly DirectorsFiverr launches AI Video Hub with independent directors delivering studio-quality content cheaper and faster than traditional Hollywood, capitalizing on 66% surge in AI video creation demand. FVRRcost reductionAI tools
GlobeNewswire Inc.·Mar 23·Rosen Law FirmSecurities Lawsuit Targets Paysafe Over Alleged Misstatements; Investors Face Filing DeadlineRosen Law Firm files securities class action against Paysafe Limited, alleging false statements about business operations and financial performance. Investors must act before lead plaintiff deadline. RGNXODDPSFEsecurities class actionlead plaintiff deadline
The Motley Fool·Mar 23·Lawrence NgaPalantir's Path to AI Dominance: The Bull Case for Enterprise OS CrownPalantir could become the operating system for enterprise AI through its integrated platform ecosystem, potentially achieving infrastructure-level economics similar to Microsoft over three years. MSFTPLTRvaluationenterprise AI
GlobeNewswire Inc.·Mar 23·NaGalapagos and Gilead Team Up on Breakthrough T Cell Engager for Autoimmune DiseasesGalapagos and Gilead plan to jointly develop an Ouro T cell engager for autoimmune diseases, splitting acquisition costs while Galapagos leads development and Gilead commercializes, freeing $500M in Galapagos cash. GILDGLPGautoimmune diseasesorphan drug designation
GlobeNewswire Inc.·Mar 23·NaGalapagos, Gilead in Advanced Talks on T-Cell Therapy PartnershipGalapagos and Gilead are in advanced partnership talks for a first-in-class T-cell engager for autoimmune diseases, with 50% cost-sharing and €500 million capital freed for Galapagos. GILDGLPGstrategic partnershipclinical development
GlobeNewswire Inc.·Mar 23·Kirby Mcinerney Llp$STLA Plunges 23.7% as Law Firm Probes Stellantis for Securities ViolationsLaw firm investigates Stellantis for potential securities violations after €22.2 billion charge announcement triggers 23.7% stock plunge to $7.28. STLAsecurities investigationstock price decline